Treatments for RA Flashcards
How many people have RA in the UK
400,000 people with RA in the UK
Approx. 12,000 new cases diagnosed each year
1% of UK population
what does synovitis of RA affect
- the joint
- tendon sheaths
- other body organs such as increased coronary artery disease
What joints are affected in RA
- small joints of hands and feet
- symmetrical
- in severe cases most joints will be affected over time
- alanto axis joint can also be damaged
describe how you diagnose RA
Joint involvement
- 1 large joint = 0
- 2-10 large joints = 1
- 1-3 small joints = 2
- 4-10 small joints = 3
- > 10 joints (at least 1 small joint = 5
Serology
- Negative RF and negative ACPA = 0
- Low positive RF or low positive ACPA = 2
- High positive RF or high positive ACPA = 3
Actue phase reactants
- Normal CRP and normal ESR = 0
- Abnormal CRP or abnormal ESR = 1
Duration of symptoms
- <6 weeks = 0
- > 6 weeks = 1
have great than or equal to 6/10 for diagnosis
What are the two things that you are trying to treat in RA
- pain relief
- modification of disease progression
how do you treat pain relief in RA
- Follow guidelines as for OA
- Analgesics and NSAIDs
- COX-2 inhibitors
What do you start of in treatment of disease modification of progression in RA
Disease modifying anti-rheumatics DMARDs
- Conventional DMARDs
- “Biologicals”
What are the two types of DMARDs
- Conventional DMARDs
- “Biologicals”
What does DMARDs stand for
Disease modifying anti-rheumatics
what is the adjunct therapy that can be used for modification of disease progression in RA
adjunct therapy = oral corticosteroid pulse
describe the treatment pathway for RA
pain manegement (newly diagnosed RA) - NSAIDs and narcotics(opioids)
First line disease treatment mild RA
- Methotrexate and second line DMARD
Second line disease treatment (moderate RA)
- methotrexate and TNF alpha inhibitor therapy
Second line disease treatment (severe RA)
- Methotrexate and rituximab
Novel disease treatments (unmanageable RA)
- Surgical interventions
What is the gold standard for RA treatment
methotrexate
what are the non pharmacological treatment that can be used for RA
- Physiotherapy
- occupational therapy
- podiatry
- therapy (relaxation, stress management, coping)
if you are newly diagnosed with RA what treatment should you get
Combination of DMARDs
- Methotrexate and at least one other DMARD plus short term glucocorticoids
If combination not appropriate (comorbities or pregnancy)
- DMARD monotherapy
- you should cautiously reduce the dosage to the level that still controls the disease
what is the only autoimmune disease that effects males more than females
Anklyisng spondlytisis
why should you not give a DMARD to pregnant women
- Drugs are often toxic and tetragenic
what is the 1st choice drug in RA
Methotrexate
when should methotrexate be given
Orally once a week on the same day
- 2.5mg tablets
- Start between 5-10mg a week
- If oral form does not work subcutaneous or intramuscular injection
How long does methotrexate take to work
3-12 weeks before benefit seen
what are the side effects of methotrexate
- can cause live problems
- can affect blood count
these need to be monitored every month to check to see if they are still working
How does methotrexate works
- folic acid antagonists
- methotrexate enters the cell through the folate carrier
- glutamate it added to it and it becomes polyglutamted within the cell
- it inhibits dihydrofolate reductase
- thus blocking the conversion of dihydrofolate to tetrahydrofolate
- this blocks synthesis for RNA and DNA
- also inhibits thymidylate synthetase
what type of drug is methotrexate
- it is an antimetabolite - prevents the cell from replicating
- normally given as an anticancer drug
What is sulfasalazine
- Antibiotics
- combines sulfapyridine and salicylate with azo bond
how do you take sulfasalazine
Orally
- Start at 500mg daily
- Gradually increased over 4 weeks to 1g twice a day
How long does it take sulfasalazine to work
12 weeks before benefits are noted
where is sulfasalazine absorbed
Not well absorbed across the gut
- Less than 15% of parent drug
- Metabolised by gut bacteria and these are better absorbed in the gut submucosa
describe the pathway of sulfasalazine
- sulfasalazine is convereted to 5 ASA in the large intestine
- then it combines its sulfapyrdine and forms N-actetyltransferase 2